Results 81 to 90 of about 828,584 (305)

BILINGUALISM AND DEVELOPMENT: A PSYCHOLOGICAL APPROACH

open access: yesИстраживања, 2015
Research on the relation between bilingualism and psychological development can be structured in many ways. This review will focus on two issues: first, empirical evidence that bilingualism is associated with several aspects of psychological development;
Lajos Göncz
doaj  

Emerging Trends in Ant–Pollinator Conflict in Extrafloral Nectary-Bearing Plants

open access: yesPlants
The net outcomes of mutualisms are mediated by the trade-offs between the costs and benefits provided by both partners. Our review proposes the existence of a trade-off in ant protection mutualisms between the benefits generated by the ants’ protection ...
Eduardo Soares Calixto   +5 more
doaj   +1 more source

The costs and benefits of replication studies

open access: yesBehavioral and Brain Sciences, 2018
AbstractThe debate about whether replication studies should become mainstream is essentially driven by disagreements about their costs and benefits and the best ways to allocate limited resources. Determining when replications are worthwhile requires quantifying their expected utility.
Coles, Nicholas   +6 more
openaire   +4 more sources

The costs and benefits of the Noise at Work Regulations 1989

open access: yes, 1997
This report forms part of the evaluation of the impact of the Noise at Work Regulations 1989 called for by the HSC. The stage of the evaluation reported in this document involved a survey of industry to establish the costs employers have incurred in ...
Jagger, N.   +3 more
core  

Benefits and costs of biologically contained genetically modified tomatoes and eggplants in Italy and Spain [PDF]

open access: yes, 2011
In this paper we assess the benefits and costs of introducing biologically contained genetically modified (GM) crops, with an application to the potential introduction of GM tomatoes and eggplants in Italy and Spain.
Wesseler, J.H.H.   +11 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

A Review of the Valuation of Environmental Costs and Benefits in World Bank Projects [PDF]

open access: yes
The World Bank’s Operational Policy on Economic Evaluation of Investment Operations requires that project evaluations include all the costs and benefits generated by the project, including environmental costs and benefits.
Patricia Silva, Stefano Pagiola
core  

Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig   +9 more
wiley   +1 more source

An Analysis of the Fifth Government Report on the Costs and Benefits of Federal Regulation [PDF]

open access: yes
This paper critically reviews the draft of the Office of Management and Budget's fifth report on the benefits and costs of federal regulation. The draft report is a significant improvement over previous reports in terms of the responsiveness to the ...
Hahn, Robert W., Litan, Robert E.
core  

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy